Biden proposes first national limits on toxic ‘forever chemicals’ in drinking water
The chemicals, known as PFAS, have been linked to health problems including certain cancers, liver damage and low birth weight.
Google is bringing A.I. chat to Gmail and Docs
Google has started testing features to create text with artificial intelligence in its Gmail and Google Docs applications.
Should you be worried about your money, your bank or the U.S. banking system? Experts weigh in
After the Silicon Valley Bank and Signature Bank failures, experts answer what a bank run is, how FDIC insurance works and whether your deposits are still safe.
Inflation gauge increased 0.4% in February, as expected and up 6% from a year ago
Excluding volatile food and energy prices, core CPI increased 0.5% in February and 5.5% on a 12-month basis.
Buy the dip in American Express shares, Wells Fargo says
Wells Fargo maintained its overweight rating on AXP in the wake of the fallout from the failure of Silicon Valley Bank. It also repeated a $200 price target.
Barclays upgrades Match shares, says Tinder parent is now a value stock
Barclays upgraded Match shares to overweight from equal weight. The firm maintained its price target of $52, implying 49.5% upside from Monday’s close price.
Deutsche Bank says Charles Schwab liquidity risks are overblown, sticks with buy rating
Charles Schwab shares were hard-hit by the selloff of financial firms’ stocks following the SVB failure.
California braces for ‘catastrophic’ floods as East and West coasts face ‘double whammy’ of storms
Storm-battered California is facing another strong Atmospheric River Event as a powerful nor’easter was already disrupting travel early Tuesday in the Northeast, forecasters said.
Wells Fargo says buy this regional bank stock that has been ‘thrown out with the bathwater,’ sees nearly 150% upside
The firm reiterated its overweight rating on the stock, while lowering its price target to $65 from $90. Still, the new price target implies 148.9% upside.
Federal judge shares date of abortion pill hearing after media outlets criticize him for secrecy
A coalition of physicians who oppose abortion asked the judge in November to order the FDA to withdraw its approval of the abortion pill mifepristone.
